BRIEF published on 05/31/2025 at 06:21, 1 day 11 hours ago Le vaccin mNEXSPIKE de Moderna contre la COVID-19 obtient l'approbation de la FDA Essai Clinique Approbation De La FDA Moderne Vaccin Contre Le Covid-19 MNEXSPIKE
BRIEF published on 05/31/2025 at 06:21, 1 day 11 hours ago Moderna's mNEXSPIKE COVID-19 Vaccine Secures FDA Approval FDA Approval COVID-19 Vaccine Clinical Trial Moderna MNEXSPIKE
PRESS RELEASE published on 05/31/2025 at 06:16, 1 day 11 hours ago Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE Moderna's mNEXSPIKE, a new COVID-19 vaccine, receives FDA approval for high-risk age groups. The vaccine shows higher efficacy compared to the original mRNA-1273. Safety profile similar to Spikevax FDA Approval COVID-19 Vaccine Moderna Efficacy MNEXSPIKE
BRIEF published on 05/29/2025 at 00:05, 3 days 17 hours ago Moderna fait état de progrès et de revers dans son programme de vaccination contre la grippe aviaire Développement De Vaccins Moderne Étude De Phase 1/2 Grippe Aviaire H5 ARNm-1018
BRIEF published on 05/29/2025 at 00:05, 3 days 17 hours ago Moderna Reports Progress and Setback in Avian Flu Vaccine Program Moderna Vaccine Development Phase 1/2 Study H5 Avian Flu MRNA-1018
PRESS RELEASE published on 05/29/2025 at 00:00, 3 days 17 hours ago Moderna Announces Update on Investigational Pandemic Influenza Program Moderna's Phase 1/2 H5 avian flu vaccine study shows positive interim results with robust immune response. HHS terminates late-stage development award Moderna Phase 1/2 Study Avian Flu Vaccine H5 Subtype HHS Termination
BRIEF published on 05/27/2025 at 13:05, 5 days 4 hours ago Moderna Announces Participation in June 2025 Conferences Investor Conferences Healthcare Webcast MRNA Technology Moderna
BRIEF published on 05/27/2025 at 13:05, 5 days 4 hours ago Moderna annonce sa participation aux conférences de juin 2025 Webcast Soins De Santé Conférences D'investisseurs Moderne Technologie De L'ARNm
PRESS RELEASE published on 05/27/2025 at 13:00, 5 days 4 hours ago Moderna to Present at Upcoming Conferences in June 2025 Moderna, Inc. announces participation in Jefferies and Goldman Sachs investor conferences, showcasing advancements in mRNA technology and COVID-19 vaccine development Investor Conferences Healthcare COVID-19 Vaccine MRNA Technology Moderna
BRIEF published on 05/23/2025 at 22:10, 8 days 19 hours ago Moderna Seeks FDA Approval for New COVID-19 Vaccine Formula COVID-19 Vaccine Moderna FDA Application Spikevax 2025-2026 LP.8.1 Variant
Published on 05/31/2025 at 06:16, 1 day 11 hours ago Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 1 day 13 hours ago Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 1 day 15 hours ago GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 1 day 18 hours ago CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 05/30/2025 at 23:00, 1 day 18 hours ago Battery X Metals Achieves Full Capacity Recovery on a Real-World Imbalanced Battery from the #2 Out-of-Warranty Electric Vehicle Model in the United States in Preliminary Trial
Published on 06/01/2025 at 10:00, 7 hours 26 minutes ago OPPO and the UEFA Champions League Final: Powering Football Innovation On and Off the Pitch
Published on 05/31/2025 at 21:00, 20 hours 26 minutes ago Leclanché annonce le dépôt d'une demande de prolongation du délai de publication du rapport annuel 2024 et la suspension temporaire de la cotation de ses actions nominatives à la SIX Swiss Exchange
Published on 05/31/2025 at 21:00, 20 hours 26 minutes ago Leclanché SA: Leclanché announces filing of request to extend the publication deadline for the 2024 Annual Report and the temporary suspension of trading of its registered shares on SIX Swiss Exchange
Published on 05/31/2025 at 18:37, 22 hours 49 minutes ago Meyer Burger files for insolvency for German subsidiaries
Published on 05/31/2025 at 14:50, 1 day 2 hours ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/30/2025 at 18:14, 1 day 23 hours ago Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 3 days 18 hours ago Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 3 days 18 hours ago Engagements collectifs de conservation de titres de la société
